Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$491M |
| 2 |
Microsoft
MSFT
|
+$352M |
| 3 |
Apple
AAPL
|
+$346M |
| 4 |
Janus Henderson Mortgage-Backed Securities ETF
JMBS
|
+$333M |
| 5 |
Cisco
CSCO
|
+$324M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Novartis
NVS
|
+$409M |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$374M |
| 3 |
State Street SPDR Portfolio Short Term Corporate Bond ETF
SPSB
|
+$347M |
| 4 |
ATVI
Activision Blizzard
ATVI
|
+$343M |
| 5 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$334M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.03% |
| 2 | Financials | 12.41% |
| 3 | Healthcare | 11.8% |
| 4 | Consumer Discretionary | 10.03% |
| 5 | Industrials | 9.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2351
CEVA Inc
CEVA
$866M
| $4.56M | ﹤0.01% |
200,670
+14,212
| +8% | +$293K |
|
2352
Montauk Renewables
MNTK
$270M
| $4.55M | ﹤0.01% |
510,922
+12,842
| +3% | +$120K |
|
2353
Danaos Corp
DAC
$2.58B
| $4.55M | ﹤0.01% |
61,404
+3,393
| +6% | +$230K |
|
2354
Treace Medical Concepts
TMCI
$312M
| $4.54M | ﹤0.01% |
355,820
+19,571
| +6% | +$198K |
|
2355
Horizon Bancorp
HBNC
$1.06B
| $4.52M | ﹤0.01% |
315,795
+3,898
| +1% | +$44K |
|
2356
Lightwave Logic
LWLG
$1.18B
| $4.51M | ﹤0.01% |
906,032
+16,890
| +2% | +$79.6K |
|
2357
Anterix
ATEX
$1.82B
| $4.5M | ﹤0.01% |
135,017
+1,593
| +1% | +$51.4K |
|
2358
Castle Biosciences
CSTL
$953M
| $4.47M | ﹤0.01% |
207,295
+6,306
| +3% | +$111K |
|
2359
RCI Hospitality Holdings
RICK
$227M
| $4.47M | ﹤0.01% |
67,456
+719
| +1% | +$41.9K |
|
2360
Cass Information Systems
CASS
$749M
| $4.46M | ﹤0.01% |
99,111
+1,106
| +1% | +$44.7K |
|
2361
NRC Health Common Stock
NRC
$460M
| $4.46M | ﹤0.01% |
112,619
+1,185
| +1% | +$49.6K |
|
2362
NerdWallet
NRDS
$634M
| $4.45M | ﹤0.01% |
302,444
+17,020
| +6% | +$188K |
|
2363
Paysafe
PSFE
$391M
| $4.45M | ﹤0.01% |
347,855
-54,237
| -13% | -$599K |
|
2364
Tarsus Pharmaceuticals
TARS
$3.01B
| $4.43M | ﹤0.01% |
218,662
+30,268
| +16% | +$505K |
|
|
UHT
2365
Universal Health Realty Income Trust
UHT
$575M
| $4.42M | ﹤0.01% |
102,261
+2,895
| +3% | +$118K |
|
2366
Columbia Financial
CLBK
$1.23B
| $4.42M | ﹤0.01% |
229,240
+2,789
| +1% | +$47.8K |
|
2367
Dyne Therapeutics
DYN
$4.87B
| $4.41M | ﹤0.01% |
331,568
+6,197
| +2% | +$60.5K |
|
2368
Comtech Telecommunications
CMTL
$52.4M
| $4.4M | ﹤0.01% |
522,507
-4,599
| -0.9% | -$48K |
|
2369
Accel Entertainment
ACEL
$1.01B
| $4.4M | ﹤0.01% |
428,692
-1,897
| -0.4% | -$19.6K |
|
|
FPI
2370
Farmland Partners
FPI
$426M
| $4.37M | ﹤0.01% |
350,172
-3,224
| -0.9% | -$37.3K |
|
2371
Apogee Therapeutics
APGE
$10.2B
| $4.35M | ﹤0.01% |
155,765
+4,407
| +3% | +$88.3K |
|
2372
York Water
YORW
$533M
| $4.35M | ﹤0.01% |
112,662
+3,152
| +3% | +$119K |
|
2373
VanEck High Yield Muni ETF
HYD
$4.41B
| $4.35M | ﹤0.01% |
84,174
-5,186
| -6% | -$257K |
|
2374
Mesa Laboratories
MLAB
$632M
| $4.34M | ﹤0.01% |
41,392
+894
| +2% | +$87.1K |
|
2375
Preformed Line Products
PLPC
$2.27B
| $4.29M | ﹤0.01% |
32,044
+750
| +2% | +$101K |
|
Similar funds
Charles Schwab's Q4 2023 Portfolio in Review
As of Q4 2023, Charles Schwab held 3,619 positions worth $394B, up 13% from $349B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Trading was light in Q4 2023: portfolio turnover was 3.5%. Charles Schwab opened 44 new positions and exited 81, leaving the 3,619-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 22% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q4 2023 buy was Janus Henderson Mortgage-Backed Securities ETF: 7,612,323 shares worth $350M.
- Charles Schwab added most to Merck in Q4 2023, an estimated $491M increase.
- Charles Schwab's biggest Q4 2023 reduction was Novartis, cutting an estimated $409M.
- Charles Schwab fully exited Activision Blizzard in Q4 2023, selling an estimated $343M.
- Charles Schwab's ten largest holdings make up 19% of its $394B portfolio in Q4 2023.
- Charles Schwab opened 44 new positions and closed 81 in Q4 2023.
- Charles Schwab's portfolio value rose 13% quarter-over-quarter to $394B.
Based on Charles Schwab's 13F filing for Q4 2023, filed 6 Feb 2024.